1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. NOVEL DRUG DELIVERY SYSTEMS MARKET BY ROUTE OF ADMINISTRATION
5.1. Introduction
5.2. Oral Drug Delivery Systems
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.3. Injectable Drug Delivery Systems
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Pulmonary Drug Delivery Systems
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.5. Transdermal Drug Delivery Systems
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
5.6. Other Routes of Administration
5.6.1. Market Trends and Opportunities
5.6.2. Growth Prospects
6. NOVEL DRUG DELIVERY SYSTEMS MARKET BY MODE OF NDDS
6.1. Introduction
6.2. Targeted Drug Delivery Systems
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Controlled Drug Delivery Systems
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
6.4. Modulated Drug Delivery Systems
6.4.1. Market Trends and Opportunities
6.4.2. Growth Prospects
7. NOVEL DRUG DELIVERY SYSTEMS MARKET BY END-USER
7.1. Introduction
7.2. Hospital
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Research Centers
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Specialty Clinics
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
7.5. Others
7.5.1. Market Trends and Opportunities
7.5.2. Growth Prospects
8. NOVEL DRUG DELIVERY SYSTEMS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Route of Administration
8.2.2. By Mode of NDDS
8.2.3. By End User
8.2.4. By Country
8.2.4.1. United States
8.2.4.1.1. Market Trends and Opportunities
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Trends and Opportunities
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Trends and Opportunities
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Route of Administration
8.3.2. By Mode of NDDS
8.3.3. By End User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Trends and Opportunities
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Trends and Opportunities
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Trends and Opportunities
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Route of Administration
8.4.2. By Mode of NDDS
8.4.3. By End User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.1.1. Market Trends and Opportunities
8.4.4.1.2. Growth Prospects
8.4.4.2. Germany
8.4.4.2.1. Market Trends and Opportunities
8.4.4.2.2. Growth Prospects
8.4.4.3. France
8.4.4.3.1. Market Trends and Opportunities
8.4.4.3.2. Growth Prospects
8.4.4.4. Italy
8.4.4.4.1. Market Trends and Opportunities
8.4.4.4.2. Growth Prospects
8.4.4.5. Spain
8.4.4.5.1. Market Trends and Opportunities
8.4.4.5.2. Growth Prospects
8.4.4.6. Others
8.4.4.6.1. Market Trends and Opportunities
8.4.4.6.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Route of Administration
8.5.2. By Mode of NDDS
8.5.3. By End User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Trends and Opportunities
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Trends and Opportunities
8.5.4.2.2. Growth Prospects
8.5.4.3. Others
8.5.4.3.1. Market Trends and Opportunities
8.5.4.3.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Route of Administration
8.6.2. By Mode of NDDS
8.6.3. By End User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.1.1. Market Trends and Opportunities
8.6.4.1.2. Growth Prospects
8.6.4.2. China
8.6.4.2.1. Market Trends and Opportunities
8.6.4.2.2. Growth Prospects
8.6.4.3. India
8.6.4.3.1. Market Trends and Opportunities
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Trends and Opportunities
8.6.4.4.2. Growth Prospects
8.6.4.5. Taiwan
8.6.4.5.1. Market Trends and Opportunities
8.6.4.5.2. Growth Prospects
8.6.4.6. Thailand
8.6.4.6.1. Market Trends and Opportunities
8.6.4.6.2. Growth Prospects
8.6.4.7. Indonesia
8.6.4.7.1. Market Trends and Opportunities
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Trends and Opportunities
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Abbott Laboratories
10.2. Amgen Inc
10.3. AstraZeneca PLC
10.4. Bayer AG
10.5. Boston Scientific Corporation
10.6. Bristol-Myers Squibb
10.7. Celgene Corporation
10.8. F. Hoffmann-La Roche AG
10.9. GlaxoSmithKline PLC